Viad Corp. (VVI) Tops Q2 EPS by 6c, Offers Guidance
Tweet
Share
E-mailGet Alerts VVI Hot Sheet
Price: $42.51 --0%
Financial Fact:
Net loss attributable to noncontrolling interest: -992K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Net loss attributable to noncontrolling interest: -992K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Viad Corp. (NYSE: VVI) reported Q2 EPS of $0.36, $0.06 better than the analyst estimate of $0.30. Revenue for the quarter came in at $320.3 million versus the consensus estimate of $300.19 million.
GUIDANCE:
Viad Corp. sees Q3 2023 revenue of $340-370 million, versus the consensus of $344 million.
For earnings history and earnings-related data on Viad Corp. (VVI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
